Most US adults with type 2 diabetes meet criteria for GLP-RAs, SGLT2is
Feb 28, 2023
More than 82% US adults with type 2 diabetes meet the criteria to be prescribed the drugs, yet only 9% use either of them.
Risk for diabetes after COVID-19 still increased during omicron phase
Feb 14, 2023
The risk for diabetes is increased after COVID-19 infection, even during the current phase dominated by omicron variants, according to a research letter published online Feb. 14 in JAMA Network Open.
Vitamin D intake linked to lower risk for progression to diabetes
Feb 07, 2023
For people with prediabetes, vitamin D supplementation also raises the likelihood of return to normal glucose regulation, physician-researchers say.
Analysis: Medication adherence spotty among U.S. diabetes patients
By
Alicia Lasek
Feb 01, 2023
A sizable percentage of patients with diabetes do not consistently take prescribed medications to lower cholesterol, glucose or blood pressure, investigators say.
Diabetes standards for 2023 include new treatment guidance, address equity
By
Alicia Lasek
Dec 14, 2022
The American Diabetes Association on Monday released its 2023 standards of care, including updates on prevention, diagnosis and treatment in a framework of equity.
Clinical briefs for Tuesday, Nov. 22
By
Alicia Lasek
Nov 22, 2022
FDA: Philips recalls some previously replaced Trilogy ventilators … Anti-hyperglycemic drugs raise risk of MS in patients with diabetes … NIH awards $12M for developing antivirals against viruses...
Cholesterol, diabetes drugs lower the prevalence of age-related degenerative eye disease: study
By
Alicia Lasek
Nov 21, 2022
Cholesterol and diabetes drugs were found to lower the prevalence of any type of age-related macular degeneration by 15% and 22%, respectively.
Race, sex disparities abound in diabetic amputation decisions
By
Kimberly Marselas
Nov 11, 2022
Black patients with a diabetic foot ulcer are more likely to have a lower limb amputated earlier than non-Hispanic White counterparts, a new study finds.
Diabetes indicators improve with use of health incentives, CDC study finds
By
Alicia Lasek
Nov 10, 2022
Incentivizing patients to follow a lifestyle modification program helps them to improve a full range of diabetes-related health measures, according to a new meta-analysis.
Common diabetes drug may serve as novel Afib treatment
By
Alicia Lasek
Oct 13, 2022
If approved, it would be the first new drug identified to treat this disease of the heart in a decade, according to Cleveland Clinic researchers.